Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎, New York, NY 10065
(646) 856-9261
[email protected]

News

Evercore ISI Annual HealthCONx Conference Fireside Chat

The Bio Report: Targeting RNA Dysregulation in Cancer